Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Fellowship - PA: CIHR/Rx&D - CAMO Research Program

McMaster University

$55,000.00

Trial of two combinations of radiation and chemotherapy in resectable cancer of the esophagus and stomach

FY 2012-13

Summary
Background: In 2010 there were 1700 individuals diagnosed with esophageal cancer in Canada; only 20% of patients survive 5 years or longer. Treatment approaches can include either a combination of chemotherapy and radiation before surgery or alternatively chemotherapy given before and after surgery without radiation. A newer radiation technique called brachytherapy (internal radiation) uses radiation seeds placed directly into the lumen of the tumor.. It is unknown how brachytherapy should be incorporated into other standard treatments for esophageal cancer. Objectives: The objective of this study is to examine 2 treatment options. One group of patients will receive brachytherapy followed by chemotherapy before surgery while the other group will receive the same chemotherapy and the usual type of external radiation followed by surgery. After surgery the pathologist will determine the number of patients who have no viable cancer left ('complete pathologic response'). Secondary objectives will determine the time it takes for the tumor to recur, the location within the body where the cancer comes back, and differences in swallowing scores. Methods: Eligible patients will have esophageal cancer and be a candidate for curative surgery. Patients must be fit enough to tolerate the treatment and not have any other major medical problems. Patients with other types of cancers will be excluded. A total of 60 patients will be included and randomly assigned to a treatment option. Significance: This study will help to determine if brachytherapy should be used in the treatment of esophageal cancer in combination with other standard treatments.
Program
Fellowship - PA: CIHR/Rx&D - CAMO Research Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
272940
Name
VanderMeer Rachel
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Medical Oncologists (Ottawa)
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Health Professional Awards - Fellowships
Projecttitle
Trial of two combinations of radiation and chemotherapy in resectable cancer of the esophagus and stomach
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$55,000
Cihrequipment2
$0
Programname2
Fellowship - PA: CIHR/Rx&D - CAMO Research Program
Keyworddelim
Brachytherapy; Esophageal Cancer; Gastric Cancer; Neoadjuvant Chemoradiotherapy; Perioperative Chemotherapy
Abstract
Background: In 2010 there were 1700 individuals diagnosed with esophageal cancer in Canada; only 20% of patients survive 5 years or longer. Treatment approaches can include either a combination of chemotherapy and radiation before surgery or alternatively chemotherapy given before and after surgery without radiation. A newer radiation technique called brachytherapy (internal radiation) uses radiation seeds placed directly into the lumen of the tumor.. It is unknown how brachytherapy should be incorporated into other standard treatments for esophageal cancer. Objectives: The objective of this study is to examine 2 treatment options. One group of patients will receive brachytherapy followed by chemotherapy before surgery while the other group will receive the same chemotherapy and the usual type of external radiation followed by surgery. After surgery the pathologist will determine the number of patients who have no viable cancer left ('complete pathologic response'). Secondary objectives will determine the time it takes for the tumor to recur, the location within the body where the cancer comes back, and differences in swallowing scores. Methods: Eligible patients will have esophageal cancer and be a candidate for curative surgery. Patients must be fit enough to tolerate the treatment and not have any other major medical problems. Patients with other types of cancers will be excluded. A total of 60 patients will be included and randomly assigned to a treatment option. Significance: This study will help to determine if brachytherapy should be used in the treatment of esophageal cancer in combination with other standard treatments.
Competitiondate
201210
Approvedterm2
2 yrs 0 mth
Pinamesdelim
VanderMeer, Rachel
Approvedterm
2 ans 0 mois
Cihrcontribution2
Patient Oriented Research~ $55,000~ $0~